Agonize This!

Join us for a psychedelics-focused conversation! Listeners of this podcast episode will enjoy discussions about the basics of serotonin and dopamine, mechanisms of action for psychedelics and antidepressants, different types of patents and their implications, and a dissection of clinical data on the subjective effects of LSD and psilocybin. 

In this episode’s game, Dr. Marcu reads a statement about a drug and panelists guess if it's in reference to a psychedelic compound or an antidepressant. For segment 2 we discuss an article written by Lauren Wilson, published by Lucid News, entitled, “A New Database Seeks to Prevent ‘Bad’ Psychedelic Patents.” This episode's peer reviewed article is a clinical comparison of LSD and psilocybin published in the Nature journal Neuropsychopharmacology in 2022. This episode features Jahan Maruc, PhD, Nigam B. Arora, PhD, Sara Jane Ward, PhD and Amber Wise, PhD.

Episode’s Group:

Jahan Marcu, PhD (moderator)

Nigam B. Arora, PhD

Sara Jane Ward, PhD

Amber Wise, PhD

Today’s Game (2:05) :

In Reference to Psychedelics or Antidepressants?

News and Popular Literature Links: 

 New Database to Prevent ‘Bad’ Psychedelics Patents

Rapid Fire Science Study Links:

Direct Comparison of the Acute Effects of Lysergic Acid Diethylamide (LSD) and Psilocybin

Credits:

Podcast audio engineering by Joe Leonardo, Cover art by illia_boo, Intro music by Buddha by Kontekst, Transition music by K. LOUK. Outro music by Bensounds.